http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29739872

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 822
issn 1538-8514
1535-7163
issueIdentifier 4
pageRange 812-822
publicationName Molecular Cancer Therapeutics
startingPage 812
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_84184d99c5f2bf62eceda3da2e558021
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_32b0a1cd7ae99f4ee32fe74686570a89
bibliographicCitation Shimizu T, Ishida J, Kurozumi K, Ichikawa T, Otani Y, Oka T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Date I. δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion. Mol Cancer Ther. 2019 Apr;18(4):812–22. doi: 10.1158/1535-7163.mct-18-0138. PMID: 30872378.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ed2bdfc30f3409a8aec223ca6278193
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e087ed68c557040f8ba39a04fc794b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1615-5125
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3c3828fa0f51386b1020ee8a55b662d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a335c3897bc8c857ca8a3009409f0547
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8798-381X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2d8c5b65f181305d651e5a1e919550f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1233-2793
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d5c7dad1cf2e294b6b47a266a9c797e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87d389d118fb9e75dbc61892951ef7b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2594-234X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a548b3c17e38a17d33d386cc4c24aee6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c2223e31e805f7f24e456c4f9e8b0fc
date 2019-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1535-7163.mct-18-0138
https://pubmed.ncbi.nlm.nih.gov/30872378
isPartOf https://portal.issn.org/resource/ISSN/1535-7163
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
https://portal.issn.org/resource/ISSN/1538-8514
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion
discusses http://id.nlm.nih.gov/mesh/M000756880
http://id.nlm.nih.gov/mesh/M0479529
http://id.nlm.nih.gov/mesh/M0406100
http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0443627
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001932Q000473
http://id.nlm.nih.gov/mesh/D000068258Q000627
http://id.nlm.nih.gov/mesh/D005910Q000188
http://id.nlm.nih.gov/mesh/D020533Q000627
http://id.nlm.nih.gov/mesh/D001932Q000188
http://id.nlm.nih.gov/mesh/D051177Q000235
http://id.nlm.nih.gov/mesh/D005910Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015972
http://id.nlm.nih.gov/mesh/D000068258Q000494
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014162
http://id.nlm.nih.gov/mesh/D000095002
http://id.nlm.nih.gov/mesh/D011923
http://id.nlm.nih.gov/mesh/D002465Q000187
http://id.nlm.nih.gov/mesh/D020533Q000008
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D000068258Q000008
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D034741Q000235
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D001932Q000401
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D020533Q000494
http://id.nlm.nih.gov/mesh/D055785
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008807
http://id.nlm.nih.gov/mesh/D009361
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D005910Q000401
http://id.nlm.nih.gov/mesh/D015996
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b003fb48d8eb2f8dbd5a1eeb0adcc254
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7839
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1500

Total number of triples: 76.